Search:        

Building Block banner
  • Building Block

    Welcome to PHARMACORE CO.,LIMITED

    　　
    PharmaCore provides custom synthesis and contract research of both catalog and non-catalog building blocks.
     
    With high quality and competitive price.
     
    Offering you the first-rate service and high-efficiency business.
     
    Air freight service: door to door services.

  • (2E)-3-(5-methyl-25-furyl)acrylic acid

    190924354(2E)-3-(5-methyl-25-furyl)acrylic acid

  • 5-chloro-4-methyl-thiazol-2-ylamine

    1909243555-chloro-4-methyl-thiazol-2-ylamine

  • 2-chloro-N,N-dimethyl-4-nitrobenzenamine

    1909243562-chloro-N,N-dimethyl-4-nitrobenzenamine

  • 3-Methyl-1,4,6,7-tetrahydrospiro[[1,3]dioxolane-2,5-indazole]

    1909243573-Methyl-1,4,6,7-tetrahydrospiro[[1,3]dioxolane-2,5-indazole]

  • 1-(4-bromo-phenyl)-cyclopentanecarboxylic acid methyl ester

    1909243581-(4-bromo-phenyl)-cyclopentanecarboxylic acid methyl ester

  • (S)-2-((Tert-butoxycarbonyl)amino)-3-(dimethylamino)propanoic acid

    190924359(S)-2-((Tert-butoxycarbonyl)amino)-3-(dimethylamino)propanoic acid

  • N-(11-bromoundecyl)carbamic acid tert-butyl ester

    190924360N-(11-bromoundecyl)carbamic acid tert-butyl ester

  • ethyl 2-(5-aminopyridin-2-yl)acetate

    190924361ethyl 2-(5-aminopyridin-2-yl)acetate

  • trans-Methyl 4-methylpyrrolidine-3-carboxylate hydrochloride

    190924362trans-Methyl 4-methylpyrrolidine-3-carboxylate hydrochloride

  • (5-bromopyridin-2-yl)Methanamine Hydrochloride

    190924363(5-bromopyridin-2-yl)Methanamine Hydrochloride

  • 1-(2-chloroethyl)-4-Methylpiperazine hydrochloride

    1909243641-(2-chloroethyl)-4-Methylpiperazine hydrochloride

  • 2-amino-N-(3-hydroxypropyl)benzamide

    1909243652-amino-N-(3-hydroxypropyl)benzamide

First Previous Page 2072 2073 2074 2075 2076 2077 2078 2079 2080 2081 2082 Next Page Last Page Total 5079Page60943 Record

Copyright @ PHARMACORE CO.,LIMITED. Our products are listed related to patents, for research purposes only, no commercial sales.

Back to the top